Clovis Oncology Inc. Stock
Your prediction
Clovis Oncology Inc. Stock
Our community identified positive and negative aspects for Clovis Oncology Inc. stock for the coming years. 2 users see the criterium "Shareholder structure" as a plus for the Clovis Oncology Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Clovis Oncology Inc. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Clovis Oncology Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Clovis Oncology Inc. | - | - | - | - | - | - | - |
| Ardelyx Inc. | 0.530% | -12.086% | -15.475% | 35.391% | 4.706% | -16.524% | - |
| Salarius Pharmaceuticals Inc. | 1.850% | 10.553% | -19.266% | -71.613% | -20.721% | -98.176% | -99.994% |
| Evolus Inc | -1.830% | -7.627% | -15.504% | 39.744% | 16.578% | 15.344% | - |
